Subscribe for the newsletter
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Mirati Therapeutics
Sort By
Newest First
Sign in
1 / 1
1 / 1
Biotechs
10 Promising Biotechs Aiming to Transform Medicine
David Alvaro, Ph.D.; Danielle Alvarez
Pharma's Almanac
PA564
Mar 22, 2022
Clinical Data
Mirati Therapeutics Presents First Clinical Data of Phase 1/2 Trial of MRTX849
Nice Insight
PR-M10-19-NI-043
Oct 29, 2019
